Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myoclonus: current concepts and recent advances.

John N Caviness1, Peter Brown

  • 1Mayo Clinic College of Medicine, Parkinson's Disease and Other Movement Disorders Center, Scottsdale, Arizona 85255, USA. jcaviness@mayo.edu

The Lancet. Neurology
|September 24, 2004
PubMed
Summary

Myoclonus, sudden involuntary muscle jerks, requires a structured approach for diagnosis and treatment. Identifying the underlying cause is key, as most cases are symptomatic and treatable.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining key qualities for transformational leadership: LLIFE leadership competencies approach.

BMJ leader·2026
Same author

Alpha-Synuclein Lesions in the Peripheral Nervous System of the Larynx in Parkinson's Disease.

Dysphagia·2025
Same author

IAPRD new consensus classification of myoclonus.

Parkinsonism & related disorders·2024
Same author

Clinical Utility of Neurophysiologic Classification (and Declassification) of Myoclonus.

Movement disorders : official journal of the Movement Disorder Society·2024
Same author

Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohort.

Parkinsonism & related disorders·2024
Same author

Conjugal Synucleinopathies: A Clinicopathologic Study.

Movement disorders : official journal of the Movement Disorder Society·2024

Area of Science:

  • Neurology
  • Neurophysiology

Background:

  • Myoclonus is characterized by sudden, brief involuntary muscle activity.
  • A systematic framework is essential for evaluating the medical significance and guiding treatment of myoclonus.
  • Clinical presentations are categorized into physiological, essential, epileptic, and symptomatic types.

Purpose of the Study:

  • To outline an organizational framework for the assessment and management of myoclonus.
  • To highlight the diverse etiologies of myoclonus, emphasizing symptomatic causes.
  • To discuss diagnostic methodologies and potential therapeutic strategies.

Main Methods:

  • Clinical presentation categorization (physiological, essential, epileptic, symptomatic).
  • Initial screening for common or correctable causes.

Related Experiment Videos

  • Further investigations including neurophysiological techniques, biochemical assays, biopsy, and genetic testing.
  • Localization of myoclonus origin (motor cortex, subcortical, brainstem, spinal, peripheral).

    • Main Results:

    • Most myoclonus cases are symptomatic, stemming from conditions like posthypoxia, toxic-metabolic disorders, drug reactions, storage diseases, and neurodegenerative disorders.
    • Assessment involves targeted screening and advanced diagnostic tests when necessary.
    • Myoclonus can originate from various parts of the nervous system, most commonly the motor cortex.

    Conclusions:

    • A structured diagnostic and treatment framework is crucial for managing myoclonus.
    • While treating the underlying cause is preferred, symptomatic treatment is an option when curative therapies are unavailable, despite limitations.
    • Further research is needed to improve evidence-based symptomatic treatments for myoclonus.